Healthcare Triangle
HCTI
1 hedge funds and large institutions have $48K invested in Healthcare Triangle in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
169% more capital invested
Capital invested by funds: $17.8K → $48K (+$30.2K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.5K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $40.3K | +$61.5K | +1 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $4.9K | – | – | – |
|
3
UBS Group
Zurich,
Switzerland
| $2.66K | – | – | – |
|
4
Fidelity Investments
Boston,
Massachusetts
| $116 | – | – | – |
|
5
Wells Fargo
San Francisco,
California
| $42 | – | – | – |
|
6
Bank of America
Charlotte,
North Carolina
| $27 | – | – | – |
|
HCTI Hedge Fund Activity: Q3 2023 in Review
1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q3 2023, worth a combined $48K — up 169% from $17.8K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new HCTI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $61.5K.
- 1 institutional investor held Healthcare Triangle (HCTI) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $48K of Healthcare Triangle stock for Q3 2023, up 169% quarter-over-quarter.
- 1 fund opened new Healthcare Triangle positions in Q3 2023 and 0 closed out, a net change of +1 holder.
- The largest Healthcare Triangle buyer in Q3 2023 was Geode Capital Management, an estimated $61.5K added.
Based on aggregated 13F filings for Q3 2023.